Heart disease is a common disease affecting human health. Electrocardiogram (ECG) classification is the most effective and direct method to detect heart disease, which is helpful to the diagnosis of most heart disease symptoms. At present, most ECG diagnosis depends on the personal judgment of medical staff, which leads to heavy burden and low efficiency of medical staff. Automatic ECG analysis technology will help the work of relevant medical staff. In this paper, we use the MIT-BIH ECG database to extract the QRS features of ECG signals by using the Pan-Tompkins algorithm. After extraction of the samples, -means clustering is used to screen the samples, and then, RBF neural network is used to analyze the ECG information. The classifier trains the electrical signal features, and the classification accuracy of the final classification model can reach 98.9%. Our experiments show that this method can effectively detect the abnormality of ECG signal and implement it for the diagnosis of heart disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818419PMC
http://dx.doi.org/10.1155/2022/9251225DOI Listing

Publication Analysis

Top Keywords

heart disease
20
diagnosis heart
12
medical staff
12
rbf neural
8
neural network
8
ecg
7
disease
6
heart
5
electrocardiogram signal
4
classification
4

Similar Publications

Artificial intelligence-based framework for early detection of heart disease using enhanced multilayer perceptron.

Front Artif Intell

January 2025

Department of Computer Science and Artificial Intelligence, College of Computing and Information Technology, University of Bisha, Bisha, Saudi Arabia.

Cardiac disease refers to diseases that affect the heart such as coronary artery diseases, arrhythmia and heart defects and is amongst the most difficult health conditions known to humanity. According to the WHO, heart disease is the foremost cause of mortality worldwide, causing an estimated 17.8 million deaths every year it consumes a significant amount of time as well as effort to figure out what is causing this, especially for medical specialists and doctors.

View Article and Find Full Text PDF

Characteristics of patients with undiagnosed stage 3 chronic kidney disease: results from an observational study (REVEAL-CKD) in China.

Lancet Reg Health West Pac

January 2025

Division of Nephrology, National Clinical Research Centre for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Background: Early diagnosis of chronic kidney disease (CKD) is crucial for timely intervention to delay disease progression and improve patient outcomes. However, data for clinical characteristics of Chinese patients with undiagnosed, early-stage CKD are lacking.

Methods: REVEAL-CKD is a multinational, observational study using real-world data in selected countries to describe factors associated with undiagnosed stage 3 CKD, time to diagnosis, and CKD management post diagnosis.

View Article and Find Full Text PDF

Background: Cardiac autonomic neuropathy (CAN) is a significant complication in chronic kidney disease (CKD), leading to increased morbidity and mortality. Early detection is essential for managing CKD patients effectively, especially those on hemodialysis. This study evaluated the prevalence CAN in CKD and diagnostic accuracy of Bellavere's Score in predicting CAN in CKD patients, including those undergoing hemodialysis.

View Article and Find Full Text PDF

Purpose: Mitoxantrone (MTX) is largely restricted in clinical usage due to its significant cardiotoxicity. Multiple studies have shown that an imbalance in the gut-heart axis plays an important role in the development of cardiovascular disease (CVD). We aim to explore the possible correlations between gut microbiota (GM) compositions and cardiometabolic (CM) disorder in MTX-triggered cardiotoxicity mice.

View Article and Find Full Text PDF

Sudden cardiac death associated with fatty liver disease.

Int J Cardiol Heart Vasc

February 2025

Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, USA.

Background: Fatty liver disease or steatotic liver disease (SLD) affects 25% of the global population and has been associated with heart disease. However, there is a lack of postmortem studies in the context of sudden cardiac death (SCD).

Objectives: To investigate the relationship between SLD and SCD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!